Proteostasis Therapeutics (PTI) - NASDAQ
Company Description
Proteostasis Therapeutics, Inc. develops disease-modifying therapeutics for orphan and neurodegenerative diseases. Its product pipeline includes cystic fibrosis and protein aggregation diseases. The firm develops its small molecule therapeutics to control the body's protein homeostasis, which is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States